These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 21700627)

  • 1. The urgent need for new antibacterial agents.
    Wise R;
    J Antimicrob Chemother; 2011 Sep; 66(9):1939-40. PubMed ID: 21700627
    [No Abstract]   [Full Text] [Related]  

  • 2. The antibacterial drugs market.
    Kresse H; Belsey MJ; Rovini H
    Nat Rev Drug Discov; 2007 Jan; 6(1):19-20. PubMed ID: 17269159
    [No Abstract]   [Full Text] [Related]  

  • 3. The antibiotic pipeline--challenges, costs, and values.
    Wenzel RP
    N Engl J Med; 2004 Aug; 351(6):523-6. PubMed ID: 15295041
    [No Abstract]   [Full Text] [Related]  

  • 4. Update on the antibacterial resistance crisis.
    Croft AC; D'Antoni AV; Terzulli SL
    Med Sci Monit; 2007 Jun; 13(6):RA103-18. PubMed ID: 17534243
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibiotics at the crossroads.
    Nathan C
    Nature; 2004 Oct; 431(7011):899-902. PubMed ID: 15496893
    [No Abstract]   [Full Text] [Related]  

  • 6. Antibacterial drug discovery: is it all downhill from here?
    Projan SJ; Shlaes DM
    Clin Microbiol Infect; 2004 Nov; 10 Suppl 4():18-22. PubMed ID: 15522036
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibacterial research and development in the 21(st) Century--an industry perspective of the challenges.
    Thomson CJ; Power E; Ruebsamen-Waigmann H; Labischinski H
    Curr Opin Microbiol; 2004 Oct; 7(5):445-50. PubMed ID: 15451498
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibiotics: a shot in the arm.
    Leeb M
    Nature; 2004 Oct; 431(7011):892-3. PubMed ID: 15496888
    [No Abstract]   [Full Text] [Related]  

  • 9. Effective antibacterials: at what cost? The economics of antibacterial resistance and its control.
    White AR;
    J Antimicrob Chemother; 2011 Sep; 66(9):1948-53. PubMed ID: 21700625
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of the pharmaceutical industry in meeting the public health threat of antibacterial resistance.
    Bergström R
    Drug Resist Updat; 2011 Apr; 14(2):77-8. PubMed ID: 21493123
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug companies snub antibiotics as pipeline threatens to run dry.
    Clarke T
    Nature; 2003 Sep; 425(6955):225. PubMed ID: 13679874
    [No Abstract]   [Full Text] [Related]  

  • 12. The 10 x '20 Initiative: pursuing a global commitment to develop 10 new antibacterial drugs by 2020.
    Infectious Diseases Society of America
    Clin Infect Dis; 2010 Apr; 50(8):1081-3. PubMed ID: 20214473
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A call to arms.
    Nat Rev Drug Discov; 2007 Jan; 6(1):8-12. PubMed ID: 17269158
    [No Abstract]   [Full Text] [Related]  

  • 14. The drug-resistant bacteria that pose the greatest health threats.
    Willyard C
    Nature; 2017 Feb; 543(7643):15. PubMed ID: 28252092
    [No Abstract]   [Full Text] [Related]  

  • 15. Drug development: Time for teamwork.
    May M
    Nature; 2014 May; 509(7498):S4-5. PubMed ID: 24784427
    [No Abstract]   [Full Text] [Related]  

  • 16. Biologics target bad bugs.
    Extance A
    Nat Rev Drug Discov; 2010 Mar; 9(3):177-8. PubMed ID: 20190776
    [No Abstract]   [Full Text] [Related]  

  • 17. A guiding hand for antibiotics.
    Jones D
    Nat Rev Drug Discov; 2011 Mar; 10(3):161-2. PubMed ID: 21358722
    [No Abstract]   [Full Text] [Related]  

  • 18. Antibiotic utilisation surveillance from pharmacoeconomic/pharmacotherapeutic standpoint with control of bacterial resistance.
    Stefan-Mikić S
    Med Pregl; 2008; 61 Suppl 1():7-8. PubMed ID: 19256063
    [No Abstract]   [Full Text] [Related]  

  • 19. Federal funding for the study of antimicrobial resistance in nosocomial pathogens: no ESKAPE.
    Rice LB
    J Infect Dis; 2008 Apr; 197(8):1079-81. PubMed ID: 18419525
    [No Abstract]   [Full Text] [Related]  

  • 20. Regulatory opportunities to encourage technology solutions to antibacterial drug resistance.
    Finch R;
    J Antimicrob Chemother; 2011 Sep; 66(9):1945-7. PubMed ID: 21700629
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.